The operation in Kabul, Afghanistan, is becoming a crucial contributor in the worldwide supply network for Abacavir Sulphate API. This national manufacturing capacity represents a substantial step beyond for the Afghan pharmaceutical market and provides a unique opportunity to mitigate dependence